Year-end Sale % OFF 
Abstract
BackgroundTo propose a combination of blood biomarkers for the prediction of hospital-acquired pneumonia (HAP) and for the selection of traumatic brain-injured (TBI) patients eligible for corticosteroid therapy for the prevention of HAP.MethodsThis was a sub-study of the CORTI-TC trial, a multicenter, randomized, double-blind, controlled trial evaluating the risk of HAP at day 28 in 336 TBI patients treated or not with corticosteroid therapy. Patients were between 15 and 65 years with severe traumatic brain injury (Glasgow coma scale score ≤ 8 and trauma-associated lesion on brain CT scan) and were enrolled within 24 h of trauma. The blood levels of CRP and cortisoltotal&free, as a surrogate marker of the pro/anti-inflammatory response balance, were measured in samples collected before the treatment initiation. Endpoint was HAP on day 28.ResultsOf the 179 patients with available samples, 89 (49.7%) developed an HAP. Cortisoltotal&free and CRP blood levels upon ICU admission were not significantly different between patients with or without HAP. The cortisoltotal/CRP ratio upon admission was 2.30 [1.25–3.91] in patients without HAP and 3.36 [1.74–5.09] in patients with HAP (p = 0.021). In multivariate analysis, a cortisoltotal/CRP ratio > 3, selected upon the best Youden index on the ROC curve, was independently associated with HAP (OR 2.50, CI95% [1.34–4.64] p = 0.004). The HR for HAP with corticosteroid treatment was 0.59 (CI95% [0.34–1.00], p = 0.005) in patients with a cortisoltotal/CRP ratio > 3, and 0.89 (CI95% [0.49–1.64], p = 0.85) in patients with a ratio < 3.ConclusionA cortisoltotal/CRP ratio > 3 upon admission may predict the development of HAP in severe TBI. Among these patients, corticosteroids reduce the occurrence HAP. We suggest that this ratio may select the patients who may benefit from corticosteroid therapy for the prevention of HAP.
Highlights
Traumatic brain injury (TBI) is the leading cause of mortality and disability among young patients throughout the world
Cortisol function and C-reactive protein (CRP) levels Despite a trend for higher total and free blood levels of cortisol upon Intensive care unit (ICU) admission, there was no significant difference between patients with or without Hospital-acquired pneumonia (HAP) (p = 0.06 and p = 0.26 respectively, Table 1)
In a large randomized trial in multiple trauma patients, we found that hydrocortisone therapy prevented the development of hospitalacquired pneumonia by day 28 in patients with Corticosteroid Insufficiency (CIRCI) (defined by a change in baseline cortisol at 60 min of < 9 μg/ dl after Adrenocorticotropic hormone (ACTH) (250 μg) administration) [12]
Summary
Traumatic brain injury (TBI) is the leading cause of mortality and disability among young patients throughout the world. It is a major health and socioeconomic problem [1, 2]. Hospital-acquired pneumonia (HAP), whose incidence ranges from 40 to 60% for severe traumatic brain-injured patients [3], is associated with poor neurologic outcome and death [4]. Elevated blood concentrations of CRP upon ICU admission are correlated with an increased risk of organ failure and death [9] and persistent systemic inflammatory response syndrome is predictive of hospital-acquired infection in trauma patients [10]. To propose a combination of blood biomarkers for the prediction of hospital-acquired pneumonia (HAP) and for the selection of traumatic brain-injured (TBI) patients eligible for corticosteroid therapy for the prevention of HAP
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
